GE HealthCare CEO reports tax withholding of shares

GE HealthCare Technologies Inc. CEO, PDx Kevin Michael O'Neill reported a tax-related share withholding on common stock.

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. CEO, PDx Kevin Michael O'Neill reported a tax-related share withholding on common stock. On February 1, 2026, 462 shares of GE HealthCare common stock were withheld at a price of $78.97 per share to cover tax obligations associated with vesting restricted stock units.

After this transaction, O'Neill beneficially owned 22,518 shares of common stock directly. He also had an additional 59 shares reported as indirectly owned through a share incentive plan trust. The filing reflects an administrative tax withholding event rather than an open-market purchase or sale.

Insider Trade Summary

Exercise Price or Tax Liability: 462 shares

Exercise Price or Tax Liability 2 txns

Insider O'Neill Kevin Michael

Role CEO, PDx

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock, par value $0.01 per share	462	$78.97	$36K
holding	Common Stock, par value $0.01 per share	--	--	--

Holdings After Transaction: Common Stock, par value $0.01 per share — 22,518 shares (Direct); Common Stock, par value $0.01 per share — 59 shares (Indirect, By share incentive plan trust)

Footnotes (1)

1. F1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did GEHC CEO Kevin O'Neill report on February 1, 2026?

Kevin O'Neill reported 462 GEHC common shares withheld at $78.97 each. The shares were withheld to satisfy tax obligations arising from vesting restricted stock units, rather than being sold in an open-market transaction.

How many GEHC shares does Kevin O'Neill beneficially own after this Form 4 filing?

After the transaction, Kevin O'Neill beneficially owned 22,518 GEHC common shares directly. The filing also reports 59 shares indirectly held through a share incentive plan trust, reflecting both his direct and indirect ownership positions.

What does transaction code F mean in the GEHC Form 4 for Kevin O'Neill?

Transaction code F on the GEHC Form 4 indicates shares were withheld to pay taxes. In this case, 462 common shares were withheld to satisfy tax withholding obligations tied to vesting restricted stock units awarded to Kevin O'Neill.

Was the February 1, 2026 GEHC insider transaction an open-market sale?

No, the GEHC transaction was not an open-market sale. The 462 shares were withheld by the company to cover tax withholding obligations related to the vesting of restricted stock units granted to Kevin O'Neill.

How are indirectly owned GEHC shares reported for Kevin O'Neill on this Form 4?

The Form 4 reports 59 GEHC common shares as indirectly owned by Kevin O'Neill. These shares are held through a share incentive plan trust, which is disclosed under the nature of indirect beneficial ownership in the filing.

What role does Kevin O'Neill hold at GE HealthCare Technologies Inc. in this Form 4?

In this Form 4, Kevin Michael O'Neill is identified as an officer of GE HealthCare Technologies Inc. He is listed with the title "CEO, PDx," indicating his leadership role within the company’s PDx business.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 07:03 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Neill Kevin Michael

(Last) (First) (Middle)

500 W. MONROE STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, PDx

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	02/01/2026		F		462(1)	D	$78.97	22,518	D
Common Stock, par value $0.01 per share								59	I	By share incentive plan trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

	/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.